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Abstract
Background: WNT-5A signaling in the central nervous system is important for morphogenesis, neurogenesis
and establishment of functional connectivity; the source of WNT-5A and its importance for cellular
communication in the adult brain, however, are mainly unknown. We have previously investigated the
inflammatory effects of WNT/β-catenin signaling in microglia in Alzheimer's disease. WNT-5A, however,
generally recruits β-catenin-independent signaling. Thus, we aim here to characterize the role of WNT-5A and
downstream signaling pathways for the inflammatory transformation of the brain's macrophages, the
microglia.
Methods: Mouse brain sections were used for immunohistochemistry. Primary isolated microglia and
astrocytes were employed to characterize the WNT-induced inflammatory transformation and underlying
intracellular signaling pathways by immunoblotting, quantitative mRNA analysis, proliferation and invasion
assays. Further, measurements of G protein activation by [γ-35 S]GTP binding, examination of calcium fluxes
and cyclic AMP production were used to define intracellular signaling pathways.
Results: Astrocytes in the adult mouse brain express high levels of WNT-5A, which could serve as a novel
astroglia-microglia communication pathway. The WNT-5A-induced proinflammatory microglia response is
characterized by increased expression of inducible nitric oxide synthase, cyclooxygenase-2, cytokines,
chemokines, enhanced invasive capacity and proliferation. Mapping of intracellular transduction pathways
reveals that WNT-5A activates heterotrimeric Gi/o proteins to reduce cyclic AMP levels and to activate a Gi/o
protein/phospholipase C/calcium-dependent protein kinase/extracellular signal-regulated kinase 1/2 (ERK1/2)
axis. We show further that WNT-5A-induced ERK1/2 signaling is responsible for distinct aspects of the
proinflammatory transformation, such as matrix metalloprotease 9/13 expression, invasion and proliferation.
Conclusions: Thus, WNT-5A-induced and G protein-dependent signaling to ERK1/2 is important for the
regulation of proinflammatory responses in mouse primary microglia cells. We show for the first time that
WNT-5A/G protein signaling mediates physiologically important processes in primary mammalian cells with
natural receptor and G protein stochiometry. Consequently, WNT-5A emerges as an important means of
astrocyte-microglia communication and we, therefore, suggest WNT-5A as a new player in neuroinflammatory
conditions, such as neurodegenerative disease, hypoxia, stroke, injury and infection.
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Background
WNT-5A belongs to the WNT family of secreted lipogly-
coproteins which is composed of 19 WNTs in mammals
and is crucial for stem cell proliferation and differentiation
during embryonic development [1-3]. During central ner-
vous system (CNS) development, WNTs regulate stem cell
proliferation and differentiation, functional integration,
axonal growth, neuronal connectivity and activity [4,5].
Recent evidence also indicates that WNTs in the adult
CNS regulate stem cells and maintain tissue homeostasis,
and they have also been implicated in neurological disor-
ders [5,6].
WNTs interact with and activate several different
cell surface receptors of which the Class Frizzled
(FZD) belongs to the group of G protein-coupled
receptors (GPCRs) [7]. WNT-5A, in contrast to, for
example, WNT-1 and -3A, generally activates β-catenin-
independent signaling [3,8-10]. In various cell systems it
was shown that WNT-5A activates WNT/Ca2+ signaling,
the WNT/RAC1 and WNT/RHO pathway [11] involving
the phosphoproteins disheveled 1, 2, 3 (DVL1, 2, 3), which
are viewed as a signaling hub relaying many WNT signal-
ing routes [12]. Further, heterotrimeric G proteins have
been implicated in WNT/FZD signal transduction [13-16]
and, indeed, recent studies confirmed a previous suppos-
ition that WNTs can induce the activation of heterotri-
meric G proteins [17-19]. Among classical downstream
targets of GPCR signaling are the mitogen-activated
protein kinases (MAPK) and especially the extracellular
signal-regulated kinases ERK1/2 [20], which can be acti-
vated by many GPCRs irrespective of which G protein
family the receptors associate with [21,22].
Here, we examined the WNT-5A-induced communi-
cation to ERK1/2 and its relevance for the inflammatory
transformation of mouse primary microglia, the im-
munocompetent cells of the CNS [23]. We show that
WNT-5A is expressed in astrocytes and that it induces a
rapid and transient phosphorylation of the ERK1/2 by re-
cruitment of Gαi/o heterotrimeric G proteins, phospholip-
ase C (PLC), calcium-dependent protein kinase (PKC) and
the MAPK/ERK1/2 kinase (MEK1/2) in microglia. Fur-
ther, recombinant and purified WNT-5A induces a proin-
flammatory transformation of mouse primary microglia as
determined by increased expression of inflammatory mar-
kers, cytokines, chemokines and matrix metalloproteases,
enhanced invasive capacities, and increased microglial
proliferation. Employing the MEK1/2 inhibitor SL327
[24], we found that microglial proliferation, invasion and
expression of matrix metalloproteases depend on the acti-
vation of heterotrimeric G proteins and the subsequent
phosphorylation of ERK1/2. Thereby, we identify a novel
function of WNT-5A as a proinflammatory regulator of
microglia and pinpoint a novel signal transduction path-
way downstream of WNT-5A with the Gαi/o protein-
dependent activation of ERK1/2 underlying distinct aspects
of the proinflammatory transformation of microglia.
Methods
Immunohistochemistry
Adult C57Bl6 mouse brains were collected and fixed in
4% paraformaldehyde (PFA) in PBS (4% PFA) for 24 h at
4°C. Fixed brains were cryoprotected in 15% to 30% su-
crose in PBS, and sectioned using a Microm HM 560
cryostat. Mouse brains were sectioned at 16 μm thick-
ness and mounted on Superfrost Plus glass slides (Thermo
Fisher Scientific Inc. Rockford, IL, USA). Sections were
treated for antigen retrieval (#S1699, DAKO Sweden AB,
Stockholm, Sweden), washed with PT20 (PBS, 0.5%
Tween-20), blocked with PBTA (PBS, 0.1% BSA, 0.3%
Triton X-100, 5% Donkey serum) and incubated with pri-
mary antibodies diluted in PBTA, overnight at 4°C. The
primary antibodies in this study included the following:
rat anti-WNT-5A (1:50, #MAB645, R&D Systems, Minne-
apolis, MN, USA), rabbit anti-IBA1 (1:500, #019-19741,
Wako, Neuss, Germany) and mouse anti-glial fibrillary
acidic protein (GFAP) Cy3 conjugated (1:250, #C9205,
Sigma-Aldrich Sweden AB, Stockholm, Sweden). After
washing with PT20, slides were incubated with secondary
antibodies diluted in PBTA for one hour at room
temperature (Alexa anti-rat 488 and Alexa anti-rabbit
647, Invitrogen, Stockholm, Sweden). Slides were washed
and mounted with mounting medium (#S3023, DAKO).
Images were captured using a confocal microscope (LSM5
Exciter, Zeiss, Jena, Germany), and a maximum intensity
projection of a Z-stack is presented (5 μm).
Primary cell cultures
Microglia cells and astrocytes were prepared from new-
born C57Bl 6 mice (postnatal day 1 to 3) according to
the ethical permits N144/08 and N436/10; local ethical
committee Stockholms Norra Djurförsöksetiska Nämnd.
After decapitation, while the brains were kept in ice cold
Hanks Balanced Salt Solution (HBSS; Invitrogen) blood
vessels and meninges were removed with sterile forceps.
Brains were rinsed four times with HBSS, and homoge-
nized in (D)MEM, penicillin (50 U/mL), streptomycin
(50 μg/mL), L-glutamine (2 mM), 10% fetal bovine serum
(FBS) and Fungizon (0.5 μg/ml) (all from Invitrogen), with
a 10 ml pipette, then ten times with a 10 ml syringe and
needle (23 G) and then filtered through a cell strainer
(70 μm; BD Falcon, Stockholm, Sweden) into a 50 ml fal-
con tube. After ten minutes centrifugation (900 g) the pel-
let was resuspended in fresh medium, filtered again and
cultured in 75 cm2 flasks (one brain/flask). Medium was
changed every fourth day, and after 10 to 12 days micro-
glia cells were separated from the underlying astrocytic
monolayer by gentle agitation. The composition of pri-
mary mixed astrocyte cultures used for Figure 1 was
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examined by immunocytochemistry using anti-GFAP
(astrocyte marker) and anti-CD11b (microglia) reveal-
ing a low degree (10% to 18%) of contamination with
CD11b-positive microglia (Figure 1E) comparable to
what was reported earlier [25]. Microglia cells could
be harvested three times from the same batch. The
purity of the microglia cultures (>95%) was validated
by cytochemistry using fluorescein isothiocyanate
(FITC)-conjugated Griffonia simplicifolia isolectin B4
(Sigma-Aldrich Sweden AB, Stockholm, Sweden) or
anti-CD11b antibody in combination with anti-GFAP
staining to assess contamination with astrocytes [see
Additional file 1: Figure S4]. Cells were challenged 24
h after plating. For isolation of primary mixed astro-
cyte cultures, the remaining cells were trypsinated
after microglia harvest and seeded according to ex-
perimental requirements.
Immunoblotting
Microglia cells were plated in a 24- or 48-well plate at a
density of 150,000 or 100,000 cells/well, respectively.
Twenty-four hours later, medium was changed to starva-
tion medium (MEM, penicillin (50 U/mL), streptomycin
(50 μg/mL; all from Invitrogen) overnight. Microglia
cells were stimulated with recombinant carrier-free
WNT-5A (CF WNT-5A; R&D Systems) and inhibitors
were added 30 min or 24 h (pertussis toxin (PTX) before
stimulation. Stimulation was stopped by addition of lysis
buffer (10% glycerol, 1% SDS, 100 mM Tris/HCl pH 7.4,
bromophenol blue, 1% mercaptoethanol). Lysates of
mixed astrocyte cultures were prepared after cells were
cultured for 24 hours in 24 well plates (500,000 cells/
well). Lysates were homogenized with a hamilton syringe
and samples were then separated through an 8% or 10%




























































Figure 1 WNT-5A expression in mouse GFAP+ astrocytes. (A) Immunohistochemistry was performed on adult mouse brain sections using an
anti-WNT-5A antibody in combination with anti-glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor protein1 (IBA1)
antibodies as astrocyte and microglia marker, respectively. Merge presents the overlay of IBA1, GFAP, WNT-5A. Size bar −2 μm. The images
represent a maximum intensity projection of a Z-stack of 5 μm thickness. The white square marked ‘B’ indicates the area magnified in B: (B) Close
up of a GFAP+ astrocyte reveals the expression of WNT-5A in this cell type. (C) shows immunoblot detection of recombinant WNT-5A (rWNT-5A;
375 ng/lane) in comparison to lysates from mouse primary microglia and mixed astrocyte cultures. β-actin serves as a loading control. (D) The bar
graph depicts expression levels of WNT-5A mRNA in mouse primary microglia and mixed astrocyte cultures measured by QPCR. Data are
normalized to GAPDH expression and analyzed with a non-parametric Mann–Whitney test. *, P< 0.05; **, P< 0.01; ***, P< 0.001. n = 4 to 8. (E)
shows indirect immunocytochemistry of mixed astrocyte cultures employing anti-GFAP as astrocyte and anti-CD11b as microglia markers. DAPI is
used as nuclear counterstain. Image represents a maximum image projection of an 8 μm Z-stack. Size bar 20 μm. The frame shows 63 cells in
total and 10 CD11b-positive microglia (arrows). Routinely 10% to 18% microglia were observed (n = 4). DAPI, 4',6-diamidino-2-phenylindole;
GADPH, glyceraldehyde 3-phosphate dehydrogenase; n, number.
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membranes (Millipore, Solna, Sweden). After blocking
with 3% milk in TBS-T, the membranes were incubated
with primary antibodies in blocking buffer: rabbit anti-
phosphospecific Thr202/Tyr204 ERK1/2 (1:1000; #9101,
Cell Signaling Technology, Boston, MA, USA), rabbit anti-
phosphospecific MEK1/2 (1:250; #9121, Cell Signaling
Technology), rabbit anti-P-LRP6 (1:1000; #2568, Cell
Signaling Technology), mouse anti-β-actin (1: 30.000;
#A5441, Sigma), mouse anti-DVL3 (1:500; #sc-8027,
Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse
anti-β-catenin (1:1000; #610154, BD Bioscience, Stockholm,
Sweden), rat anti-WNT-5A (1:500; #MAB645, R&D
Systems), rabbit anti-iNOS (1:1000; #N7782, Sigma), goat
anti-COX-2 (1:500; #sc-13474, Santa Cruz) and goat anti-
TNFα (1:500; #AF-410-NA, R&D Systems) overnight at
4°C. The proteins were immunodetected with appropriate
horseradish peroxidase-conjugated secondary antibodies
(goat anti-rabbit and goat anti-mouse (Pierce, Rockford,
IL, USA) and rabbit anti-goat (Sigma) that were visualized
by the enhanced chemiluminescence method (Western-
Lightning, PerkinElmer, Waltham, MA, USA).
RNA isolation and PCR
Microglia cells and mixed astrocytes cultures were
seeded in six-well plates (Costar) at a density of 1.2 mil-
lion/well. After 24 hours, cells were starved for four
hours and then stimulated for six hours with CF WNT-
5A/control (ctrl). RNA was isolated using the RNeasy
Mini kit (Qiagen, Hilden, Germany) and transcribed
to cDNA using the high-capacity cDNA Archive kit
(Applied Biosystems, Foster City, CA, USA). QPCR
was performed in triplicate on an ABI Prism 7000 se-
quence detector and with the Taqman gene expression
assay (Applied Biosystems) according to the manufac-
turer’s instructions. Primer efficiency was previously tested
by the manufacturer and shown to be close to 100% for all
used primers. Additionally, primer efficiency was evalu-
ated using the CT slope method over six serial cDNA dilu-
tions indicating similar efficiencies close to 100% for
all primers at the conditions used for analysis. All
primer pairs were from Applied Biosystems: TNF-α:
Mm00443260_g1, IL1β: Mm00434228_m1, IL6: Mm9
9999064_m1, IL12: Mm01288991_g1, CCl12: Mm016
17100_m1, CCl7: Mm00443113_m1, MMP9: Mm004
429941_m1, MMP13: Mm00439491_m1, CD69: Mm0
1183378_m1, CD40: Mm00441891_m1, Cox-2 (Ptgs2):
Mm00478374_m1, Fzd1: Mm01320682_s1, Fzd2: Mm025
24776_s1, Fzd3: Mm00445923_m1, Fzd4: Mm03053
556_s1, Fzd5: Mm00445623_s1, Fzd6: Mm00433383_m1,
Fzd7: Mm01255614_s1, Fzd8: Mm00433419_s1, Fzd9:
Mm01206511_s1, Fzd10: Mm00558396_s1. As an in-
ternal reference standard primers for GAPDH were
used (ΔCt = Ct, target gene - Ct, GAPDH), ΔCt was pre-
sented as relative fold change in gene expression
(mean ± standard error of the mean (s.e.m)) indicated
as arbitrary units, target gene/GAPDH. RT-PCR was
performed with cDNA from unstimulated microglia in
a 2720 Thermo Cycler (Applied Biosystems) using the
following standard program: five minutes at 94°C; 30
cycles of 30 seconds at 94°C; 45 seconds at Tanneal; one mi-
nute at 72°C; ten minutes at 72°C. PCR products were run
on 2.5% agarose gels and visualized using GelRed fluores-
cent nucleic acid gel stain (Biotium, Stockholm, Sweden).
For primer sequences and Tanneal see [17].
[γ35 S]-GTP assay in microglia membranes
Cells were seeded in 60 mm dishes (4 to 5 million cells/
dish). After 48 hours, cell plasma membrane proteins
were isolated using the ProteoJet membrane protein ex-
traction kit (Fermentas, Heidelberg, Germany) according
to instructions provided by the manufacturer. [γ35 S]
GTP assay was performed as previously described [17].
In brief, the assay was performed in a 96-well filter plate
(Millipore) in which 10 μg/well of pre-activated (one
hour, 37°C) membrane protein were incubated (one
hour, 30°C) with 300 ng/ml WNT-5A or vehicle control
(0.01% BSA in PBS) in the presence of 0.25 nM [γ35 S]-
GTP (Perkin Elmer) and 5 μM GDP (Sigma-Aldrich).
All substances and protein were diluted in assay buffer
(100 mM NaCl, 10 mM MgCl2, 20 mM HEPES, pH 7.4)
to a final volume of 300 μl/well. Subsequently, the plate
was washed three times with 0.9% saline solution using
vacuum filtration and dried overnight at 60°C. Thirty
microliters per well Optiphase supermix scintillation li-
quid (Perkin Elmer) were added and the incorporation of
[γ35 S]-GTP was measured using a MicroBeta2 LumiJET
Scintillation counter (Perkin Elmer).
cAMP assay
Intracellular cAMP levels were determined using a com-
petitive protein binding assay and [3H]-cAMP. Briefly,
cells were plated into 24 well microplates, grown over-
night and stimulated at 37 °C. The reaction was stopped
by addition of perchloric acid to a final concentration of
0.4 M and incubation on ice. After lysis and neutralization
with KOH in 50 mM Tris, the supernatant was examined
for cAMP content as described elsewhere [26].
[Ca2+]i imaging
Primary microglia cells were harvested and placed in
35 mm dishes (100,000 cells per dish) coated with ECM
Gel from Engelbreth-Holm-Swarm murine sarcoma
(Sigma-Aldrich). Cells were loaded for 15 minutes at
37°C with 10 μM Fluo-3/AM and 0.2% pluronic acid
(F-127, Invitrogen) and incubated for an additional 15
minutes at 37°C in (D)MEM with HEPES (12 mM) at
pH 7.45. Experiments were performed at 37°C with con-
tinuous perfusion at 1 ml/minute with a peristaltic
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pump, on the stage of a Zeiss inverted microscope and
water immersion Zeiss C-Apochromat 40x/1.20 water
correction M27 objective. Fluo-3 (excitation: 488 nm,
emission: 526 nm; recorded range 503–629 nm) images
were acquired every four seconds using Zen 2009 soft-
ware (Zeiss). Measurements were performed on micro-
glial cell bodies by using amplification rates that prevent
saturation of the fluorescence signal and a preliminary
calibration of the Ca2+ measurements.
Mesoscale
Primary microglia were stimulated with WNT-5A for 24
hours. The cell medium was cleared by centrifugation
and analyzed for TNFα protein by a 96 well mouse cyto-
kine immunoassay (Meso Scale Discovery, Gaithersburg,
MD, USA) according to the manufacturer’s instructions.
TNFα concentrations in samples were compared with a
dilution standard curve of recombinant TNFα. Plates were
analyzed with the SECTOR instrument and software.
MTT-assay
Cells were seeded in a 96-well plate (40,000 cells/well).
The next day, medium was changed to starvation medium
(total volume 100 μl/well) for an additional 24 hours, after
which cells were challenged with 300 ng/ml CF WNT-5A
(R&D Systems). After 24 hours of stimulation, 20 μl of 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium brom-
ide (MTT) reagent solution (5 mg/ml in PBS; Sigma)
were added to each well, and also in a set of wells without
cells to analyze background, and incubated for 3.5 hours
at 37°C to allow for mitochondrial reduction of tetrazoles
to formazan. After aspiration of the MTT solution, 150 μl/
well solvent (4 mM HCl and 0.1% Nonidet P-40 in isopro-
panol) were added and the plate was agitated for 20 min-
utes on an orbital shaker. Absorbance was read at 570 nm
using a plate reader with a reference filter at 620 nm.
Increases in MTT were interpreted as increased prolifera-
tion since mitochondrial/metabolic activity correlates with
cell number.
Invasion assay
A collagen mixture containing 10x (D)MEM, 5% NaHCO3
(pH 8.97), HEPES 1 M (pH 7.5) and rat collagen I (final
concentration 3.6 mg/ml, Gibco, Stockholm, Sweden) was
placed on top of an extracellular matrix (ECM) gel
(Sigma) coated 24-well glass bottom plate (MatTek
Corporation, Ashland, MA, USA). After 90 minutes, the
gel was fully polymerized and 50,000 fluorescently labeled
primary microglia (cell tracker red 5 μM for 30 minutes,
Invitrogen) in αMEM growth medium containing either
CF WNT-5A (300 ng/ml; R&D systems) or PBS were
placed on top of the layer. The next day, invasion of
microglia into the collagen matrix was measured with a
confocal microscope LSM710 system (Zeiss), scanning
three random positions per condition and using Z-stack
measurement with an EC Plan-Neofluar 10x/0.30 M27
objective, a 561 nm laser for excitation and an emission
range of 566/683 nm. During scanning, cells were kept in
a humidified atmosphere at 37°C and 5% CO2. Z-stacks
were acquired with ZEN 2009 software. To quantify the
percentage of invasion (cells that moved a minimum of
20 μm from the top layer), the invading cells were divided
by the total number of cells, employing the particle tracker
function in Imaris 7.2 software (Bitplane). The results are
shown for three independent experiments and invasion is
normalized to the control.
Statistical analysis
Statistical and graphical analysis was performed using
the Graph Pad Prism 5 software. All data, except quantita-
tive PCR experiments were analyzed with one-way ana-
lysis of variance (ANOVA) followed by a Bonferroni's
multiple comparison post hoc test. Quantitative PCR
experiments were analyzed with a non-parametric Mann–
Whitney test. All experiments were repeated at least three
independent times. Levels of statistical significance: *,
P< 0.05; **, P< 0.01; ***, P< 0.001.
Results
WNT-5A is expressed in astrocytes in vivo
In order to address the role of WNT-5A for intercellular
communication in the adult brain, we asked first of all,
which cells express the WNT-5A protein. Immunohisto-
chemistry in brain sections from adult mice with a rat-anti
WNT-5A antibody in combination with an astrocyte
(anti-GFAP) and a microglia marker (anti-IBA1) revealed
strong overlap of WNT-5A- and GFAP-like immunoreac-
tivity in the whole brain. Figure 1A, B show cortical
WNT-5A- and GFAP-positive astrocytes and closely asso-
ciated with IBA1-positive but WNT-5A-negative micro-
glia. These data are supported by detection of WNT-5A
protein and mRNA in primary microglia and mixed astro-
cyte cultures with immunoblotting (Figure 1C) and quan-
titative PCR (Figure 1D), respectively. The high expression
levels of WNT-5A in mixed astrocyte cultures compared
to microglia suggest a possible paracrine WNT-5A-based
communication from astrocytes to microglia.
WNT-5A stimulation of microglia results in
phosphorylation of ERK1/2
Activation of MAPKs is of central importance for the
regulation of microglia activity in response to a pleth-
ora of stimuli ranging from lipopolysaccharides to
cytokines, chemokines and neurotransmittors [27-29].
We hypothesized that WNT-5A, which is expressed
in and secreted from astrocytes rather than by micro-
glia themselves (Figure 1A, B) could regulate the in-
flammatory potential of microglia, possibly through
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MAPKs. These cells express suitable WNT-5A sur-
face receptors as shown in Additional file 1: Figure
S1 and in a previously published study [30]. In
mouse primary microglia isolated from newborn
mice, recombinant and purified WNT-5A increased
the phosphorylation of ERK1/2 in a time- and dose-
dependent manner (Figure 2A, B). The WNT-5A-
evoked ERK1/2 phosphorylation was rapid with
increased levels at ten minutes post-stimulation and
maximal induction (138.2 ± 6.2% of ctrl; mean ± s.e.m.)
at 30 minutes. Two hours after WNT stimulation, P-
ERK1/2 levels had returned to basal. Substantial effi-
cacy of WNT-5A could be detected at 300 ng/ml, a
dose which has been previously shown to be effective
to induce WNT-5A signaling in other cell types
[31,32]. In order to confirm the specificity of the
WNT-5A-induced P-ERK1/2 response we employed
recombinant soluble FZD-related protein 1, which
completely blocked the WNT-5A-induced ERK1/2
phosphorylation [see Additional file 1: Figure S2].
In parallel to the WNT-5A-induced ERK1/2 phosphor-
ylation, we assessed phosphorylation of LRP6, β-catenin
stabilization and the formation of phosphorylated and
shifted DVL3 (PS-DVL3) [see Additional file 1: Figure
S3]. According to previous findings in other cell types,
WNT-5A did not activate the WNT/β-catenin pathway,
but increased the formation of PS-DVL in a time- and
dose-dependent manner [8,31].
WNT-5A activates heterotrimeric Gαi/o proteins and
induces [Ca2+]i in microglia
Since WNT-5A-induced signaling to ERK1/2 has not
been described in detail yet, we aimed to characterize
more closely the underlying signaling components. First
of all, we used PTX as an inhibitor of Gαi/o proteins and
show that pretreatment with PTX (100 ng/ml overnight)
completely abrogated the WNT-5A-induced ERK1/2
phosphorylation (P-ERK1/2), indicating that activation
of Gαi/o is upstream of the WNT-5A-induced P-ERK1/2
(Figure 3A). On the other hand, PTX did not affect the
WNT-5A-induced formation of PS-DVL (Figure 3B)
similar to previous findings in SN4741 cells [31] arguing
that G protein and DVL signaling could be distinct
branches of WNT signaling. These biochemical data are
supported by immunocytochemistry experiments show-
ing that cellular P-ERK1/2 immunoreactivity was
increased in microglia stimulated with WNT-5A, an ef-
fect which was also blocked by PTX pretreatment
(Figure 3C).
In order to test the assumption that WNT-5A-induced
ERK1/2 phosphorylation not only requires active Gαi/o
protein but that WNT-5A also directly activates Gαi/o, we
performed G protein activation assays in membrane pre-
parations from mouse primary microglia stimulated with
recombinant WNT-5A (Figure 4A). Activation of hetero-
trimeric G proteins is measured as an exchange of GDP to
GTP, employing a hydrolysis-resistant 35 S-labelled GTP
ng/ml
WNT-5A
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Figure 2 WNT-5A induced a transient phosphorylation of ERK1/2. WNT-5A stimulation of mouse primary microglia induced ERK1/2
phosphorylation in a time- (A; 300 ng/ml WNT-5A) and dose-dependent (B; 30 minutes WNT-5A) manner. Bar graphs provide a summary of
densitometric analysis of three independent experiments. Data were normalized to the response in ctrl-stimulated microglia. Variation is shown as
s.e.m. (n≥ 3). *, P< 0.05; **, P< 0.01; ***, P< 0.001. ctrl, control; ERK1/2, extracellular signal-regulated kinase 1/2; n, number; s.e.m, standard error
of the mean.
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analogue, [γ-35 S]GTP. Crude [γ-35 S]GTP binding assays
in mammalian cell membranes are generally suitable to
assess GPCR-mediated activation of Gαi/o proteins,due to
the advantageous signal to noise ratio in comparison to
Gαs or Gαq/11 proteins [33]. As shown in Figure 4A,
WNT-5A stimulation resulted in GDP/GTP exchange,
demonstrating that WNT-5A activates Gαi/o proteins with
157.7 ± 4.3% of control (mean± s.e.m.) at physiological
stochiometry of receptors and G proteins. In order to
characterize the expression profile of PTX-sensitive Gαi/o
subunits in primary microglia, we performed RT-PCR
(Figure 4B), which revealed expression of Gαi1, i2, i3, o but
not Gαt1, 2, 3. Consequently, WNT-5A-induced stimula-
tion in microglia can potentially activate Gαi1-3 and Gαo.
Gαi/o-coupled GPCRs typically reduce cAMP levels
through Gαi/o subunits and induce changes in intracellular
calcium ([Ca2+]i) through the release of βγ and the subse-
quent phospholipase C (PLC)-dependent production of
inositoltrisphosphate and calcium release from the endo-
plasmatic reticulum [22].
WNT-5A was indeed capable of reducing forskolin-
induced cAMP levels in a dose-dependent manner, func-
tionally confirming the activation of Gαi/o proteins
(Figure 4C). In order to visualize WNT-5A-induced
changes in [Ca2+]i we used Fluo-3-loaded primary
microglia cells for live cell imaging. As shown in
Figure 4D-F, 300 ng/ml WNT-5A led to a fast and
transient increase in [Ca2+]i in a PTX-sensitive manner
reminiscent of previous observations in mammalian cells
[34,35].
WNT-5A recruits a Gαi, PLC, PKC, MEK1/2 signaling axis to
regulate ERK1/2
Classical Gαi/o-coupled GPCRs can recruit numerous
pathways to activate ERK1/2 [22]. Based on our data on G
protein activation and calcium mobilization, we
hypothesized that WNT-5A could recruit PLC, Ca2+
and Ca2+-dependent PKC in order to feed into the clas-
sical MAPK cascade. To characterize the WNT-5A-
induced pathway to ERK1/2 in more detail, we employed
a series of pharmacological inhibitors [see also Additional
file 1: Table S1]: M119 (inhibits βγ-effector interaction);
U73122 (inhibits PLC); bisindolmaleimide VIII (BIS; inhi-
bits PKC); BAPTA-AM (a [Ca2+]i chelator); wortmannin
and LY294002 (inhibit phosphatidylinositol-3'-kinase/
PI3K); SL327 (inhibits MEK1/2); and D4476 (casein kinase
1 inhibitor). Preincubation with M119, U73122, BIS, and
SL327 but not wortmannin/LY294002 or D4476 com-
pletely blocked the WNT-5A-induced ERK1/2 response
(Figure 5A), suggesting the involvement of βγ release,
PLC, PKC and MEK1/2 but not PI3K and CK1. The activ-
ity of D4476 was confirmed by analysis of PS-DVL3 levels:
since the formation of PS-DVL3 is dependent on CK1 we




























C P-ERK1/2 IBA1 DAPI
ctrl WNT-5A WNT-5A+PTX
Figure 3 WNT-5A-induced ERK1/2 phosphorylation requires activation of Gαi/o. (A) Primary microglia, pretreated with PTX (100 ng/ml,
overnight), were stimulated with 300 ng/ml WNT-5A for 30 minutes and their total cell lysate was analyzed for P-ERK1/2 by immunoblotting. β-
actin serves as a loading control. Densitometric analysis of three independent experiments is summarized in the bar graph (error bars - s.e.m.). **,
P< 0.01. (B) In a similar stimulation paradigm, cells were lysed after two hours and the lysate was analyzed for the formation of PS-DVL3 (filled
triangle: DVL3, open triangle: PS-DVL3). n = 3. (C) Indirect immunocytochemistry and confocal microscopy were used to detect and localize P-
ERK1/2 in ctrl, WNT-5A (300 ng/ml, 30 minutes) and WNT-5A/pertussis toxin (PTX, 100 ng/ml)-treated mouse primary microglia. IBA1 was used as
a microglia marker and DAPI as nuclear counterstain. Arrows mark WNT-5A-responsive microglia with increased P-ERK1/2 levels (n = 3). Size
bar = 50 μm. ctrl, control; DAPI, 4',6-diamidino-2-phenylindole; DVL, disheveled; ERK1/2, extracellular signal-regulated kinase 1/2; IBA1, ionized
calcium-binding adaptor protein1; n, number; P-ERK1/2, ERK1/2 phosphorylation; PS-DVL, phosphorylated and shifted DVL; s.e.m., standard error of
the mean.
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treatment (Figure 5B) comparable to previous data
obtained in other cell types [31,36].
Hence, our data indicate the involvement of βγ subu-
nits released from Gαi/o, PLC, PKC, and MEK1/2 in the
WNT-5A-induced signaling axis to ERK1/2 and its inde-
pendence from CK1, PS-DVL3 formation and PI3K. The
active involvement of MEK1/2 is corroborated by direct
immunoblotting showing that MEK1/2 is phosphory-
lated upon WNT-5A treatment. In addition, we show
that BIS and U73122 block WNT-5A-mediated MEK1/2
phosphorylation, confirming that it is regulated by the
same upstream components (Figure 5A).
In summary, this suggests that WNT-5A can activate
PS-DVL-dependent pathways, which we have not inves-
tigated in more detail in this study. In addition, WNT-
5A activates heterotrimeric G protein signaling, which
leads to a reduction in cAMP levels and the activation of
ERK1/2 through engagement of βγ subunits, PLC, PKC,
and MEK1/2. The ERK1/2 cascade is an established pro-
liferative pathway with proinflammatory function in
microglia [20,28,29,37]. Thus, based on the signaling
profile induced by WNT-5A we suggest that its effects
might be of a proliferative and proinflammatory nature
in mouse primary microglia.
Increased expression of iNOS, COX-2 and TNFα upon
WNT-5A exposure
To assess the proinflammatory potential of WNT-5A we
initially employed immunoblotting to measure regula-
tion of proinflammatory markers, which are generally
induced upon activation of microglia: inducible nitric
oxide synthase (iNOS), cyclooxygenase 2 (COX-2) and
TNFα. iNOS generates the reactive and cell perme-
able mediator nitric oxide, COX-2 is a crucial player
in prostanoid synthesis and TNFα is an important
proinflammatory cytokine. Six-hour stimulation with
300 ng/ml WNT-5A increased iNOS, COX-2 and
TNFα expression substantially (Figure 6A, B). In
order to support the TNFα protein expression data
from cell lysates with information on WNT-5A-
induced mediator release, supernatants from ctrl- and
WNT-5A-stimulated primary microglia were analyzed for
TNFα by Mesoscale measurements, indicating an increased
release of proinflammatory TNFα (Figure 6B’).
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Figure 4 WNT-5A-induced G protein activation mediates decrease in cAMP and mobilization of [Ca2+]i. (A) Isolated plasma membranes
from mouse primary microglia were stimulated with WNT-5A (300 ng/ml) as described in the Methods section to assess activation of
heterotrimeric G proteins. Incorporation of [γ-35 S]GTP, a measure for activation of G proteins, was quantified by scintillation counting. Data from
three independent experiments are shown in the bar graph. ***, P< 0.001. Error bars give s.e.m.. (B) cDNA from mouse primary microglia was
analyzed for expression of PTX-sensitive variants of the Gi/o family of Gα subunits by RT-PCR. cDNA synthesis was performed in the absence and
presence of RT (+/− RT) to control for the purity of the preparation. (C) Detection of intracellular cAMP levels reveals that WNT-5A reduces
forskolin-induces cAMP production in a dose-dependent manner (error bars: s.e.m.; n = 3; **, P< 0.01; ***, P< 0.001.). (D-F) Stimulation of
Fluo-3-loaded primary microglia with WNT-5A induced fast and transient elevation of [Ca2+]i. ATP was used as a positive control. The [Ca
2+]i trace
shown in D originates from a single cell. Typically 15% to 30% of the cultured microglia responded to WNT-5A. (E) shows a representative view of
Fluo-3-loaded cells at baseline and upon WNT-5A (300 ng/ml) exposure. The images are pseudocolored with warm colors presenting high [Ca2+]i
and cold colors low [Ca2+]i. Size bar 20 μm. The bar graph summarizes data from five different experiments with ATP and WNT-5A in
combination with PTX. Error bar gives s.e.m. n, number; PTX, pertussis toxin; s.e.m., standard error of the mean.
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Microglia proliferate and invade in response to WNT-5A
stimulation
When microglia cells are activated in vivo, they prolifer-
ate and are attracted to the site of injury. The substantial
proinflammatory transformation induced by WNT-5A
indicated by expression of iNOS, COX-2 and TNFα
prompted us to investigate the cellular behavior of
WNT-5A-stimulated primary microglia. The WNT-5A-
induced activation of ERK1/2, a well-known mediator of
cell proliferation, suggested that WNT-5A could also have
mitogenic effects. Indeed, stimulation with 300 ng/ml
WNT-5A increased mitochondrial activity by143.9± 11.2%
(mean± s.e.m.) of control as assessed by an MTT assay
(Figure 6C) as well as cell number [see Additional file 1:
Figure S5], which in combination is interpreted as an
increased proliferation. Employing both PTX and the
ethanol-soluble SL327 in combination with the MTT assay,
we found support for the hypothesis that the Gαi/o-PLC-
PKC-MEK1/2-ERK1/2 signaling axis is also important for
the WNT-5A-mediated regulation of microglial prolifera-
tion (Figure 6C, D). Enhanced capability to invade into the
surroundings is a hallmark of microglial activation. Thus,
we implemented a three-dimensional collagen invasion
assay to assess the invasion of microglia into a collagen
matrix. Strikingly, WNT-5A (300 ng/ml; one day) evoked
substantial invasion into the collagen matrix as shown
in Figure 6E, F. Again, the MEK1/2 inhibitor SL327
blocked the WNT-5A-induced invasive effects com-
pletely (Figure 6F).
To further characterize the inflammatory effects of
WNT-5A on microglia we charted the inflammatory
fingerprint of WNT-5A by gene expression analysis.
Quantitative PCR revealed increased expression of the
inflammation-related genes IL1β, IL6, IL12, TNFα, CC
motif chemokine CCL7, CCL12, clusters of differentiation
CD40, CD69, and matrix metalloproteases MMP9 and
P-ERK
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Figure 5 Mapping of the WNT-5A-induced signaling pathway
leading to ERK1/2 phosphorylation in primary microglia. (A)
Cells were treated with pharmacological inhibitors 10 minutes prior
to WNT-5A challenge (300 ng/ml, 20 minutes). Immunoblotting
analysis of P-ERK1/2 and P-MEK1/2 is shown. β-actin serves as
loading control. Representative data from at least three experiments
are shown and data are quantified in the bar graphs next to each
inhibitor (error bars - s.e.m.; *, P< 0.05; **, P< 0.01; ***, P< 0.001). (B)
Lysates from microglia treated with WNT-5A in the absence or
presence of D4479 were analyzed for the formation of PS-DVL3. (C)
Table summarizes concentrations, targets and effects of the
inhibitors used. Pharmacological inhibitors: D4476, CK1 inhibitor;
M119, βγ inhibitor; U73122, PLC inhibitor; BIS,(bisindolmaleimide VIII),
PKC inhibitor; wortmannin/LY294002, phosphatidylinositol-3'-kinase
inhibitor; BAPTA-AM, Ca2+-chelator; SL327, MEK1/2 inhibitor. DVL3,
disheveled 3; ERK1/2, extracellular signal-regulated kinase 1/2; MEK1/
2, MAPK/ERK kinase 1/2; PKC, calcium-dependent protein kinase; PLC,
phospholipase C; PS-DVL3, phosphorylated and shifted DVL3; s.e.m,
standard error of the mean.
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MMP13 after six hours of treatment with 300 ng/ml
WNT-5A (Figure 6G). The observed shift in the expres-
sion profile of inflammatory genes with diverse functions
clearly corroborates the proinflammatory action of WNT-
5A in microglia.
Since we have shown that WNT-5A-induced signaling
to ERK1/2 is responsible for the recorded proliferative
and invasive effects, we used the MEK1/2 inhibitor
SL327 to assess the role of ERK1/2 signaling in the

































































































































































































































Figure 6 WNT-5A induces a proinflammatory transformation in mouse microglia. (A, B) iNOS, COX-2 and TNFα were detected by
immunoblotting in lysates from mouse primary microglia after WNT-5A stimulation (ctrl, 300 ng/ml, 6 hours). (B’) shows TNFα levels in the
supernatant of primary microglia under ctrl conditions and upon WNT-5A stimulation (ctrl, 300 ng/ml, 24 hours; n = 4). At least three experiments
are summarized in the bar graphs. Data are normalized to ctrl. Error bars give s.e.m. (C) Microglial proliferation was assessed by an MTT assay
monitoring mitochondrial activity, which is proportional to cell number [see Additional file 1: Figure S5]. Stimulation with WNT-5A (300 ng/ml, 24
hours) increased MTT, which was blocked by PTX (100 ng/ml, overnight) or the MEK1/2 (10 μM) inhibitor, SL327. (D). Experiments were done in
triplicate and data from three independent experiments are shown. *, P< 0.01; ***, P< 0.001: Error bars show s.e.m.. (E) Cell tracker (red)-stained
primary microglia were seeded on top of a collagen matrix in 35 mm glass bottom dishes. One day after ctrl or 300 ng/ml WNT-5A stimulation,
invasion was observed by confocal microscopy and Z-stacking using a Zeiss LSM710 microscope and subsequent analysis with the Bitplane Imaris
software. The size of the collagen cube shown is 1,000 (Z) x 1,400 (Y) x 1,400 (X) μm. Three invasion experiments in the absence and presence of
the MEK1/2 inhibitor SL327 were quantified. Data are presented in a bar graph (F). *, P< 0.05; error bars show s.e.m.. (G) cDNA of ctrl stimulated
(−) and WNT-5A stimulated (+) primary microglia was analyzed by QPCR for expression of inflammatory genes. At least three independent
experiments are summarized. Gene expression is normalized to the housekeeping gene GAPDH and expressed as arbitrary units (2-Δct). *, P< 0.05;
**, P< 0.01. COX-2, cyclooxygenase 2; iNOS, inducible nitric oxide synthase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; n,
number; s.e.m., standard error of the mean.
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shown in Table 1, WNT-5A-induced expression of genes
for inflammatory markers was affected by SL327 in a bi-
directional manner: whereas the increase of MMP9 and
MMP13 expression was clearly blocked by MEK1/2 in-
hibition, the WNT-5A-induced effects on TNFα, CCL7,
CCL12, COX-2, and CD40 expression were instead amp-
lified when MEK1/2 was inhibited.
The table summarizes QPCR data obtained from
mouse primary microglia stimulated with 300 ng/ml
WNT-5A for six hours in the presence and absence of
the MEK1/2 inhibitor SL327 (10 μM). Numbers provide
the percentage of WNT-5A-induced increase over ctrl
or SL327 treatment alone. Results are presented as arbi-
trary units (fold change of unstimulated control micro-
glia, 2-ΔΔCt). The ratio provides a relative measure of
decrease (value <1) or increase (>1) of gene expression
upon treatment with SL327. Results from at least four
independent experiments are shown. Variations are
given as s.e.m. *, P< 0.05; **, P< 0.01.
Discussion
WNT-5A, which is predominantly expressed in astrocytes
in the adult mouse brain, evokes a proinflammatory trans-
formation of microglia characterized by increased expres-
sion of cytokines, chemokines and metalloproteases and
changes in microglial proliferation and invasiveness. We
have characterized underlying signaling pathways, identi-
fying a Gαi/o-PLC-PKC-MEK-ERK1/2 signaling axis (see
also Figure 7) as necessary for some but not all aspects of
the WNT-5A-induced inflammatory transformation.
Thus, we report for the first time that WNT-5A-induced
signaling through heterotrimeric G proteins and the
ERK1/2 cascade is activated in cells with endogenous stoi-
chiometry of WNT receptors and G proteins and that this
has physiological relevance for the regulation of microglia
in the brain and, thus, for the CNS immune response.
WNT-5A-evoked proinflammatory transformation of
microglia
The establishment and maintenance of regional and
phenotypic differences in activated microglia are so far
only poorly understood. The spectrum of WNT-5A-
induced changes suggests that microglia become activated,
motile, proliferative, and communicate with their sur-
roundings by means of secreted mediators. IL1β, IL6, IL12
and TNFα act proinflammatory and are known to be
secreted by activated microglia in many different con-
ditions, such as neurodegenerative disease, trauma or
infection [23,38]. These cytokines serve mainly for com-
munication with surrounding microglia, macroglia and
neurons but also infiltrating immune cells. In addition, we
have investigated the expression of CC motif chemokines,
namely CCL7 and CCL12, which are also known as
monocyte chemotactic protein 3 and 5, respectively. These
chemokines are important for monocyte and leukocyte re-
cruitment, indicating that WNT-5A-activated microglia
could serve to engage peripheral, infiltrating immune cells
to support neuroinflammatory processes [39,40]. Also, ex-
pression of CD40, a member of the tumor necrosis factor
receptor family, and CD69, a C type lectin, serve for com-
munication with astrocytes and peripheral immune cells,
such as lymphocytes and natural killer cells [41]. Further,
cytokines and chemokines are known to act both in a
paracrine and autocrine manner, suggesting that their
WNT-5A-induced release could also support communica-
tion among microglia to promote and spread the in-
flammatory response [42]. Additional transmission of
inflammatory signals is accomplished by the WNT-
5A-induced upregulation of iNOS and COX-2, which
both have a crucial role in the inflammatory reaction
and produce nitric oxide (NO) and prostaglandins, re-
spectively [43].
Regulation of MMPs by WNT-5A
In addition to increasing NO-, prostaglandin-, cytokine-
and chemokine-based intercellular communication, WNT-
5A enhanced MMP9 and MMP13 expression, suggesting a
role in extracellular matrix remodeling. The function of
MMPs in the brain is complex and includes promotion of
cell invasion as well as disruption of the blood–brain bar-
rier [44-46]. Thus, increased invasion of microglia and
recruitment of peripheral immune cells could be a conse-
quence of MMP secretion from WNT-5A-stimulated
microglia. Indeed, this assumption is supported by
the WNT-5A-induced microglial invasion in the col-
lagen three dimensional invasion assay (Figure 5E,
F). Furthermore, MMPs contribute to the processing,
activation and release of non-extracellular matrix pro-
teins, such as growth factors, cytokines, FAS ligand,
E-cadherin, integrins, and additional MMPs by a
process called ectodomain shedding [47]. MMP13,
Table 1 Inhibition of MEK1/2 by SL327 blocks WNT-5A-
induced expression of matrix metalloproteases.
Gene WNT-5A WNT-5A/SL327 Ratio
IL1β 209.8 ± 78.2 88.1 ± 16.3 0.4
IL6 947.0 ± 554.4 541.0 ± 175.8 0.6
IL12 33622.0 ± 26855.0 31504.0 ± 14202.0 0.9
TNFα 43.0 ± 5.7 366.3 ± 84.5** 8.5
CCL7 29.1 ± 5.1 574.7 ± 348.2* 19.7
CCL12 26.7 ± 7.0 354.7 ± 206.3** 12.9
COX-2 93.3 ± 30.4 448.3 ± 169.9* 4.8
CD40 558.0 ± 133.0 1989.0 ± 398.0** 3.6
CD69 456.0 ± 155.0 1723.0 ± 606.0 3.8
MMP9 5.1 ± 1.2 1.0 ± 0.1* 0.2
MMP13 28.3 ± 8.0 6.7 ± 0.9** 0.2
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primarily a collagenase, is known to cleave many sub-
strates [48], among others heparan sulfates. Since
MMP13 was shown to promote the release of basic
fibroblast growth factor [49] it similarly could release
heparan sulfate-bound WNTs thereby amplifying
WNT action in the inflammatory microenvironment.
WNT-5A-induced ERK1/2 signaling in microglia
In order to address the role of MEK1/2, the upstream
kinase of ERK1/2, for the WNT-5A-induced changes in
gene expression, we chose SL327 over more widely used
PD98059 or UO126 because SL327 showed a higher
solubility in ethanol over dimethyl sulfoxide (DMSO)
among those substances. DMSO might interfere with
the microglia integrity and activity status in long time
stimulation paradigms, such as six or 24 hour, as used in
the present study.
Most interestingly, WNT-5A-evoked MMP expression
could be blocked by the MEK1/2 inhibitor SL327
(Table 1). On the other hand, WNT-5A-induced TNFα,
CCL7, CCL12, COX-2 and CD40 expression was
enhanced in the presence of MEK1/2 inhibition. These
findings suggest a central regulatory role of the WNT-
5A-ERK1/2 pathway that is able to integrate proinflam-
matory input through a bidirectional regulation of gene
expression. It appears that proinflammatory WNT-5A
stimulation of primary microglia establishes a distinct re-
active phenotype based on an integral inhibitory autoregu-
lation through ERK1/2. ERK1/2 exerts an inhibitory input
towards the ERK1/2-independent, WNT-5A-induced
upregulation of TNFα, CCL7, CCL12, COX-2 and
CD40, unmasked by simultaneous MEK1/2 inhibition
(Table 1). Hypothetically, WNT-5A-induced ERK1/2
phosphorylation could also provide negative crosstalk
with other proinflammatory agents, thereby limiting
the inflammatory transformation or shifting it to-
wards a more invasive and proliferative phenotype.
So far we are not able to identify a candidate path-
way, where the WNT-5A-ERK1/2 axis could exert
negative regulation. The proposed crosstalk of WNT-5A-
induced ERK1/2 activation to attenuate other signaling
systems could take place on different levels, such as the
receptor level, intermediate signaling components, or the


























Figure 7 Schematic overview of the results from the present study indicating WNT-5A secretion from astrocytes and the WNT-5A-
induced signaling pathway towards ERK1/2 regulating distinct aspects of the proinflammatory transformation of microglia.
Pharmacological inhibitors used in the study: D4476, pertussis toxin (PTX), M119, BAPTA-AM, U73122, bisindolaleiimide (BIS), SL327. Abbreviations:
AC, adenylyl cyclase; cAMP, cyclic AMP; DAG, diacylglycerol; DVL, disheveled; ERK1/2, extracellular signal-regulated kinases 1/2; FZD, Frizzled; IP3,
inositoltriphosphate; MEK1/2, MAPK/ERK kinase 1/2; MMP, matrix metalloprotease; PLC, phospholipase C; PKC, Ca2+-dependent protein kinase; Gi,
heterotrimeric G proteins of the Gi/o family; WNT, Wingless/int-1.
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pinpoint candidate links and to map the underlying
mechanisms of this regulatory crosstalk.
MAPK signaling in general and ERK1/2 in particular is
a well-established pathway underlying CNS inflamma-
tion [28,50]. WNT-5A stimulation of primary microglia
leads to a Gαi/o, PLC, Ca
2+, PKC, MEK1/2-dependent
phosphorylation of ERK1/2, similar to pathways previously
described for Gαi/o-coupled GPCRs [22]. Accordingly,
Gαi/o-independent signaling could induce ERK1/2-inde-
pendent aspects of microglial activation, for example, via
formation of PS-DVL. ERK1/2 signaling downstream of
GPCRs can almost be seen as a default pathway irrespect-
ive of the heterotrimeric G proteins involved and agonist-
induced activation of ERK1/2 is localized downstream of
many different GPCRs [22].
However, WNT-induced signaling towards ERK1/2 can-
not be observed as a general readout, which is confirmed
by unpublished observations indicating that WNT-5A
does not induce P-ERK1/2 upon 10 minutes of stimula-
tion in human embryonic kidney cells (HEK293), mouse
embryonic fibroblasts, a substantia nigra-derived dopa-
minergic precursor cell line SN4741 or N13 microglia-like
cells (not shown).
Astrocytes as source of proinflammatory WNT-5A
Establishment of reactive microglia upon CNS damage
precedes the development of astrogliosis, but both pro-
cesses have overlapping inflammatory functions in CNS
pathology [51]. Secreted factors from microglia are
known to affect astrocytes and vice versa. During mid-
brain neurogenesis, astrocytes and radial glia were
shown to increase the number of Nurr1 dopaminergic
precursors through WNT-5A secretion [52], indicating
that astroglia are an important source of CNS WNT-5A
during development. Our findings now show that cultured
astrocytes isolated from newborn mice and astrocytes in
intact mouse brain tissue express WNT-5A suggesting a
paracrine communication between astrocytes and sur-
rounding cells such as microglia and neurons. Further, we
show that mouse primary microglia in comparison to
astrocytes express lower levels of WNT-5A mRNA and
protein indicating that an autocrine regulation of micro-
glia by WNT-5A could exist but that this might be of
minor importance.
So far, the regulation of WNT-5A release from astro-
cytes to accomplish a proinflammatory transformation
of surrounding microglia remains obscure. Since WNT-
5A protein levels in astrocytes are prominent also under
normal conditions, we suggest that regulation of release
mechanisms, possibly depending on transcriptional or
functional regulation of Porcupine or WNTless [53] under
proinflammatory conditions, could result in increased se-
cretion of WNT-5A.
Putative role of WNT-5A-induced proinflammatory
transformation in pathophysiology
Although the role of WNT-5A for brain development has
been mapped in some detail, less is known of its involve-
ment in brain disorders in the adult [5,6,54,55]. So far it is
not known if levels of WNT-5A or its receptors are dy-
namically regulated under pathophysiological conditions,
such as neurodegenerative disease, infection, trauma, hyp-
oxia or other inflammatory conditions. One exception is
brain tumors and metastases, which have been associated
with overexpression of WNT-5A [56,57]. Brain tumors
also increase the astrocyte- and microglia-dependent im-
mune response and the presence of activated tumor-
associated microglia was reported a long time ago [58]. In
fact, recent data show that WNTs, and especially WNT-
5A, signaling in microglia/macrophages, can promote
invasiveness of breast cancer cells and especially their me-
tastasis in the brain [59-61]. Most importantly, our study
shows that microglia cells are WNT-receiving cells, which
interpret WNT-5A stimulation with a strong proinflam-
matory output.
Conclusions
In summary, we identify WNT-5A originating from
astrocytes as a proinflammatory regulator of microglia,
capable of increasing their number and invasiveness,
thereby supporting basic immune function in the CNS.
Further, we show that distinct subsets of WNT-5A-
induced effects on microglial function are mediated
through the ERK1/2 cascade. Thus, we conclude that
WNT-5A has an important role to define a distinct
proinflammatory phenotype of microglia in pathophysio-
logical conditions associated with neuroinflammation.
Future studies will reveal the putative crosstalk between
G protein-dependent and -independent WNT-5A signal-
ing in microglia and its role for the establishment and
maintenance of a reactive microglia phenotype under
different neuroinflammatory conditions.
Additional file
Additional file 1: Figure S1: FZD expression in mouse primary
microglia. The bar graph depicts expression levels of FZD1-10 in mouse
primary microglia measured by quantitative PCR. Error bars provide
standard SEM. N = . Probe efficiency for GAPDH and FZD probes was
determined using the CT slope method over six cDNA dilutions. Slope/R2
in %: GAPDH: - 3.3745/99.96%; FZD1: -3.5317/99.88%; FZD2: -3.5317/
99.88%; FZD3: -3.2678/99.82%; FZD4: -.4883/99.64%; FZD5: -3.4356/97.65%;
FZD6: -3.2966/99.65%; FZD7: -3.6285/99.56; FZD8: -3.3238/99.98%; FZD9: -
3.3352/99.99%; FZD10: -3.2384/99.40%. Thus, direct comparison and
quantitative statements about relative FZD expression levels are justified.
We have previously reported that expression levels of non-GPCR
coreceptors for WNTs, such as ROR1/2 and RYK, are low in both microglia
cell lines and primary microglia (Halleskog et al., 2011; Kilander et al.,
2011). Figure S2: In order to confirm the specificity of the WNT-5A-
induced P-ERK1/2 response and to exclude unspecific responses of
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microglia to putative contaminants in the WNT preparation, we
employed recombinant soluble FZD-related protein 1 (SFRP1). SFRP1
binds WNTs thereby preventing their interaction with the receptor
(Kawano and Kypta, 2003; Kilander et al., 2011). Stimulation of primary
microglia with WNT-5A (300 ng/ml) in the presence of SFRP1 (10 μg/μl)
did not result in increased P-ERK1/2 arguing that SFRP1 sequesters WNT-
5A selectively preventing its effects. N = 3. Figure S3: WNT-5A-induced β-
catenin-independent WNT signaling. (A) Immunoblotting analysis of
WNT-3A and WNT-5A stimulated cell lysates from mouse primary
microglia cells reveals a WNT-5A-induced formation of PS-DVL3 but a lack
of β-catenin stabilization and LRP6 phosphorylation. WNT-5A induced the
dynamic formation of PS-DVL3 in a time- (B) and dose-dependent (C)
manner. β-actin was employed as a loading control. N ≥3. Figure S4:
Mouse primary microglia cultures seeded on gelatin-coated glass cover
slips were routinely stained with indirect immunocytochemistry for the
microglia marker CD11b and glial fibrillary acidic protein (GFAP).
Counterstaining for nuclear DNA was done with DAPI. Cellular
morphology is shown in the bright field image. Microglia culture
contained >95% CD11b+/GFAP- cells with microglial morphology.
GFAP+ astrocytes were only detected occasionally. Size bar: 50 μm.
Figure S5: Mouse primary microglia cultures were stimulated with ctrl or
300 ng/ml WNT-5A for 24 hours. Cells were then manually counted in a
Bürker chamber and data (normalized to control) summarized in a bar
graph. WNT-5A increased cell number to 129.2 ± 6.5 (mean ± s.e.m.).
Variation is shown as s.e.m. (n = 4). **, P <0.01. Table S1:
Pharmacological inhibitors used in this study [62,63].
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